(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual revenue growth rate of 25.69% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.45%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Ekso Bionics Holdings's revenue in 2024 is $17,913,000.On average, 1 Wall Street analysts forecast EKSO's revenue for 2024 to be $391,658,880, with the lowest EKSO revenue forecast at $391,658,880, and the highest EKSO revenue forecast at $391,658,880. On average, 1 Wall Street analysts forecast EKSO's revenue for 2025 to be $505,430,787, with the lowest EKSO revenue forecast at $505,430,787, and the highest EKSO revenue forecast at $505,430,787.
In 2026, EKSO is forecast to generate $646,464,333 in revenue, with the lowest revenue forecast at $646,464,333 and the highest revenue forecast at $646,464,333.